Article info

Download PDFPDF
Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: a substudy of the China salt substitute and stroke study (SSaSS)

Authors

  1. Correspondence to Dr Maoyi Tian, The George Institute for Global Health at Peking University Health Science Center, Beijing, China; mtian{at}georgeinstitute.org.cn
View Full Text

Citation

Huang L, Yu J, Neal B, et al
Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: a substudy of the China salt substitute and stroke study (SSaSS)

Publication history

  • Received March 9, 2020
  • Revised October 8, 2020
  • Accepted November 14, 2020
  • First published December 7, 2020.
Online issue publication 
May 10, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.